Sheridan reappointed as FDA consultant

Brett C. Sheridan

Brett C. Sheridan, M.D., a cardiac surgeon and associate professor in the UNC Division of Cardiothoracic Surgery, has been reappointed by the U.S. Food and Drug Administration as a consultant to the FDA’s Circulatory System Devices Panel. He will also serve as a consultant to other panels of the FDA’s Medical Devices Advisory Committee, and to its Center for Devices and Radiological Health.

As a consultant, Dr. Sheridan reviews and evaluates data on safety and effectiveness of marketed and investigational devices. He has served in this role since 2007, and was recently reappointed to serve until November 2015.